Compare XBIT & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | VIOT |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.0M | 65.8M |
| IPO Year | 2015 | 2018 |
| Metric | XBIT | VIOT |
|---|---|---|
| Price | $2.41 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.3K | ★ 177.9K |
| Earning Date | 05-08-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 13.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.04 |
| P/E Ratio | ★ N/A | $3.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $0.92 |
| 52 Week High | $3.61 | $4.33 |
| Indicator | XBIT | VIOT |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 37.23 |
| Support Level | $2.35 | $0.93 |
| Resistance Level | $2.41 | $1.05 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 4.00 | 11.82 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.